Marchesini, Giulio

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 2,581

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 1,277

Insulin resistance: a metabolic pathway to chronic liver disease

Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 900

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 850

Advancing the global public health agenda for NAFLD: a consensus statement

Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 757

Metformin in non-alcoholic steatohepatitis.

Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 682

Obesity-Associated Liver Disease

Marchesini, G., Moscatiello, S., Di Domizio, S., & Forlani, G. (2008) · The Journal of Clinical Endocrinology & Metabolism

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 359

Non-alcoholic fatty liver disease: A patient guideline

Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 264

The Effect of Lutein on Eye and Extra-Eye Health

Buscemi, S., Corleo, D., Di Pace, F., Petroni, M. L., Satriano, A., & Marchesini, G. (2018) · Nutrients

Antioxidant Activity and Oxidative StressRetinal Diseases and Treatments

Cited by 260

Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

Piccinni, C., Motola, D., Marchesini, G., & Poluzzi, E. (2011) · Diabetes Care

Pharmacovigilance and Adverse Drug ReactionsMetabolism, Diabetes, and Cancer

Cited by 239

Psychological status and depression in patients with liver cirrhosis

Bianchi, G., Marchesini, G., Nicolino, F., Graziani, R., Sgarbi, D., Loguercio, C., Abbiati, R., & Zoli, M. (2005) · Digestive and Liver Disease

Liver Disease and TransplantationLiver Diseases and Immunity

Cited by 187

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems

Raschi, E., Poluzzi, E., Salvo, F., Pariente, A., De Ponti, F., Marchesini, G., & Moretti, U. (2018) · Nutrition, Metabolism and Cardiovascular Diseases

Pharmacovigilance and Adverse Drug ReactionsDiabetes Treatment and Management

Cited by 119

Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges

Petroni, M. L., Brodosi, L., Marchignoli, F., Sasdelli, A. S., Caraceni, P., Marchesini, G., & Ravaioli, F. (2021) · Nutrients

Nutritional Studies and DietDiabetes Treatment and Management

Cited by 116

Anticatabolic Effect of Branched–Chain Amino Acid–Enriched Solutions in Patients With Liver Cirrhosis

Marchesini, G., Zoli, M., Dondi, C., Bianchi, G., Cirulli, M., & Pisi, E. (1982) · Hepatology

Clinical Nutrition and GastroenterologyLiver Disease and Transplantation

Cited by 99

Prevention and treatment of sarcopenic obesity in women

Petroni, M. L., Caletti, M. T., Dalle Grave, R., Bazzocchi, A., Aparisi Gómez, M. P., & Marchesini, G. (2019) · Nutrients

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 82

Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study

and the QUOVADIS Study Group, Marchesini, G., Cuzzolaro, M., Mannucci, E., Grave, R. D., Gennaro, M., Tomasi, F., Barantani, E. G., & Melchionda, N. (2004) · International Journal of Obesity

Eating Disorders and BehaviorsObesity, Physical Activity, Diet

Cited by 68

Effects of cognitive–behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder

Marchesini, G., Natale, S., Chierici, S., Manini, R., Besteghi, L., Di Domizio, S., Sartini, A., Pasqui, F., Baraldi, L., Forlani, G., et al. (2002) · International Journal of Obesity

Eating Disorders and BehaviorsObesity, Physical Activity, Diet

Cited by 58

Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?

Mazzotti, A., Caletti, M. T., Marchignoli, F., Forlani, G., & Marchesini, G. (2017) · Digestive and Liver Disease

Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment

Cited by 46

Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM

Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsLiver Disease Diagnosis and Treatment

Cited by 38

Evidence-Based Medicine and the Problem of Healthy Volunteers

Marchesini, G., Marchignoli, F., & Petta, S. (2017) · Annals of Hepatology

Liver Disease Diagnosis and TreatmentEthics in Clinical Research

Cited by 13

Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs

Petroni, M. L., Brodosi, L., Armandi, A., Marchignoli, F., Bugianesi, E., & Marchesini, G. (2023) · Nutrients

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 12

Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study

The Italian Society of Emergency Medicine (SIMEU), Veronese, G., Marchesini, G., Forlani, G., & Fabbri, A. (2016) · Acta Diabetologica

Diabetes Management and ResearchMedical Coding and Health Information

Cited by 7